BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3184067)

  • 1. Deposition of C3 on bacteria in the mouse uterus after mating.
    Parr EL; Parr MB
    J Reprod Immunol; 1988 Mar; 12(4):315-9. PubMed ID: 3184067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secretory immunoglobulin binding to bacteria in the mouse uterus after mating.
    Parr EL; Parr MB
    J Reprod Immunol; 1985 Aug; 8(1):71-82. PubMed ID: 4045831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-bacterial IgA and IgG in mouse uterine luminal fluid, vaginal washings and serum.
    Parr EL; Parr MB
    J Reprod Immunol; 1988 Jun; 13(1):65-72. PubMed ID: 3418618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deposition of C3b and iC3b onto particulate activators of the human complement system. Quantitation with monoclonal antibodies to human C3.
    Newman SL; Mikus LK
    J Exp Med; 1985 Jun; 161(6):1414-31. PubMed ID: 2409200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding ability of complement receptor CR1 to C3 bound on the surface of M+ group A streptococci.
    Hong K; Harada T; Nishimura T; Inoue K
    Immunology; 1993 Dec; 80(4):640-4. PubMed ID: 8307615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A quantitative method for assessing the third complement factor (C3) attached to the surface of opsonized Pseudomonas aeruginosa: interrelationship between C3 fixation, phagocytosis and complement consumption.
    Engels W; Endert J; Van Boven CP
    J Immunol Methods; 1985 Jul; 81(1):43-53. PubMed ID: 3926902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of C-reactive protein to the pneumococcal capsule or cell wall results in differential localization of C3 and stimulation of phagocytosis.
    Holzer TJ; Edwards KM; Gewurz H; Mold C
    J Immunol; 1984 Sep; 133(3):1424-30. PubMed ID: 6747291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amidation of C3 at the thiolester site: stimulation of chemiluminescence and phagocytosis by a new inflammatory mediator.
    Gordon DL; Krueger RA; Quie PG; Hostetter MK
    J Immunol; 1985 May; 134(5):3339-45. PubMed ID: 3980996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of C3 deposition and degradation on bacterial surfaces after opsonization.
    Gordon DL; Rice J; Finlay-Jones JJ; McDonald PJ; Hostetter MK
    J Infect Dis; 1988 Apr; 157(4):697-704. PubMed ID: 3279137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opsonization of bacteroides by the alternative complement pathway reconstructed from isolated plasma proteins.
    Bjornson AB; Magnafichi PI; Schreiber RD; Bjornson HS
    J Exp Med; 1987 Mar; 165(3):777-98. PubMed ID: 3819646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The covalent interaction of C3 with IgG immune complexes.
    Vivanco F; Muñoz E; Vidarte L; Pastor C
    Mol Immunol; 1999; 36(13-14):843-52. PubMed ID: 10698338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mannose-binding lectin (MBL) facilitates opsonophagocytosis of yeasts but not of bacteria despite MBL binding.
    Brouwer N; Dolman KM; van Houdt M; Sta M; Roos D; Kuijpers TW
    J Immunol; 2008 Mar; 180(6):4124-32. PubMed ID: 18322223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional and structural characterization of four mouse monoclonal antibodies to complement C3 with potential therapeutic and diagnostic applications.
    Subías Hidalgo M; Yébenes H; Rodríguez-Gallego C; Martín-Ambrosio A; Domínguez M; Tortajada A; Rodríguez de Córdoba S; Llorca O
    Eur J Immunol; 2017 Mar; 47(3):504-515. PubMed ID: 28083930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Degradation of complement 3 by streptococcal pyrogenic exotoxin B inhibits complement activation and neutrophil opsonophagocytosis.
    Kuo CF; Lin YS; Chuang WJ; Wu JJ; Tsao N
    Infect Immun; 2008 Mar; 76(3):1163-9. PubMed ID: 18174338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of intravenous immune globulin on complement-dependent immune damage of cells and tissues.
    Frank MM; Basta M; Fries LF
    Clin Immunol Immunopathol; 1992 Jan; 62(1 Pt 2):S82-6. PubMed ID: 1728991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65.
    Ollert MW; Kadlec JV; Petrella EC; Bredehorst R; Vogel CW
    Cancer Res; 1993 Feb; 53(3):592-9. PubMed ID: 8425193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the interactions between properdin, the third component of complement (C3), and its physiological activation products.
    Farries TC; Lachmann PJ; Harrison RA
    Biochem J; 1988 May; 252(1):47-54. PubMed ID: 3421908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opsonization of encapsulated Staphylococcus aureus: the role of specific antibody and complement.
    Verbrugh HA; Peterson PK; Nguyen BY; Sisson SP; Kim Y
    J Immunol; 1982 Oct; 129(4):1681-7. PubMed ID: 7108223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement C3 deposition onto bacteria by neonatal serum is not enhanced after the infusion of intravenous immunoglobulin.
    Lassiter HA; Speranza MJ; Hall RT; Meade V; Christensen RD; Parker CJ
    J Perinatol; 1990 Mar; 10(1):27-31. PubMed ID: 2107285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody-independent activation of C1 by type Ia group B streptococci.
    Eads ME; Levy NJ; Kasper DL; Baker CJ; Nicholson-Weller A
    J Infect Dis; 1982 Nov; 146(5):665-72. PubMed ID: 6752296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.